POS1197 IN DEPTH IDENTIFICATION OF RISK FACTORS FOR SEVERE COVID-19, REQUIRING HOSPITALIZATION, IN PATIENTS WITH INFLAMMATORY RHEUMATIC DISEASES: RESULTS OF A DUTCH NESTED CASE CONTROL STUDY (PRELIMINARY RESULTS)
Background: Several risk factors for severe COVID-19 have been identified 1 . An important question is whether in addition to these generic risk factors, patients with a potentially altered immune response, either by disease (inflammatory rheumatic diseases (IRDs)) or use of immunomodulatory agents (IA), carry a higher or lower risk of severe COVID-19. In addition, several other potential risk factors for severe COVID-19 have been suggested, such as vitamin D status and specific medication (NSAIDs, ACE-inhibitors) 2 . Objectives: To identify risk factors for severe COVID-19, requiring hospital... Mehr ...
Verfasser: | |
---|---|
Dokumenttyp: | Artikel |
Erscheinungsdatum: | 2021 |
Reihe/Periodikum: | Annals of the Rheumatic Diseases ; volume 80, issue Suppl 1, page 880.2-881 ; ISSN 0003-4967 1468-2060 |
Verlag/Hrsg.: |
BMJ
|
Schlagwörter: | General Biochemistry / Genetics and Molecular Biology / Immunology / Immunology and Allergy / Rheumatology |
Sprache: | Englisch |
Permalink: | https://search.fid-benelux.de/Record/base-26649683 |
Datenquelle: | BASE; Originalkatalog |
Powered By: | BASE |
Link(s) : | http://dx.doi.org/10.1136/annrheumdis-2021-eular.1853 |